Risk Of Developing Liver Cancer After HCV Treatment

Thursday, February 14, 2013

Dr Steve Ryder describes new treatments for Hepatitis C currently in trials and new devices used for assessment

Published on Feb 13, 2013
Dr Steve Ryder describes new treatments for Hepatitis C currently in trials and new devices used for assessment. He then provides coherent and convincing arguments to urge clinicians to get more deeply involved in clinical research. Finally, Dr Ryder summarises the key drivers that promote successful engagement with the pharmaceutical industry.

Dr Ryder is Consultant Physician in Hepatology and Gastroenterology at Nottingham University Hospitals NHS Trust. He is also Chair of the NIHR Hepatology Specialty Group.
 


No comments:

Post a Comment